Abstract
BackgroundSJIA is a distinct and debilitating form of arthritis associated with elevated cytokine (interleukin [IL]-1 and IL-6) levels.1 Studies have shown that biologics (IL-1 and IL-6 inhibitors), including canakinumab (CAN),...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have